Jane Street
CLPT icon

Jane Street’s ClearPoint Neuro CLPT Stock Holding History

Jane Street’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Sell
18,700
-2,400
-11% -$30.3K ﹤0.01% 10289
2025
Q4 		$289K Sell
21,100
-18,200
-46% -$337K ﹤0.01% 8919
2025
Q3 		$856K Buy
+39,300
New +$463K ﹤0.01% 6660
2021
Q4 		– Sell
-45,000
Closed -$799K – 10130
2021
Q3 		$799K Buy
+45,000
New +$844K ﹤0.01% 6364

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jane Street's CLPT Position: Q1 2026 in Review

Jane Street sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 35,124 shares — an estimated $443K sold.

Jane Street first reported a position in CLPT in Q3 2021 and held it in 12 quarters. The position peaked at $3.42M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Jane Street reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 35,124 ClearPoint Neuro shares in Q1 2026, an estimated $443K.
  • Jane Street first reported a position in ClearPoint Neuro in Q3 2021 and held it in 12 quarters.
  • Jane Street's ClearPoint Neuro position peaked at $3.42M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.